Stock 300583 SHANDONG SITO BIO-TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Shandong Sito Bio-technology Co., Ltd.

Equities

300583

CNE100002F36

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 22/05/2024 am IST 		5-day change 1st Jan Change
14.07 CNY +0.57% Intraday chart for Shandong Sito Bio-technology Co., Ltd. -3.76% -28.87%
08/05 Shandong Sito Bio-technology Gets European Suitability Certification for Rhinitis Nasal Spray MT
28/04 Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shandong Sito Bio-technology Gets European Suitability Certification for Rhinitis Nasal Spray
MT
Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shandong Sito Bio-Technology Co., Ltd. Appoints Kang Li as Independent Director
CI
Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shandong Sito Bio-technology in Talks to Buy 60% of Local Steroid Maker for 46 Million Yuan
MT
Shandong Sito Bio-technology Co., Ltd. agreed to acquire 60% stake in Yingu Pharmaceutical Co., Ltd. from Yingu Holding Group for approximately CNY 460 million.
CI
Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shandong Sito Bio-Technology Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 28 June 2023
CI
Shandong Sito Bio-technology Co., Ltd. Proposes Final Cash Dividend for 2022
CI
Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shandong Sito Bio-technology Co., Ltd. announced that it has received CNY 261.590392 million in funding from a group of investors
CI
Sito Bio-technology Selling 300 Million Yuan Shares to Fund New Factory
MT
Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shandong Sito Bio-Technology Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 05 July 2022
CI
Shandong Sito Bio-technology Co., Ltd. announced that it expects to receive CNY 298.0822 million in funding from a group of investors
CI
Shandong Sito Bio-technology Co., Ltd. Approves Cash Dividend for the Year 2021
CI
Shandong Sito Bio-Technology Co., Ltd. Proposes Final Dividend for 2021
CI
Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300583 Stock
  4. News Shandong Sito Bio-technology Co., Ltd.